ShockWave Medical stock is trading -34.2% below its average target price of $270.82 after dropping -17.1% during today's evening session. Analysts are giving the mid-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $165.0 to $330.0 per share.
ShockWave Medical has an average level of shares sold short, at 6.0% of its total share float. The stock's short ratio (also called days to cover) is 3.39. Since 1.18% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests.
Institutional investors own 93.3% of ShockWave Medical's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in ShockWave Medical
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Blackrock Inc. | 10% | 3,636,444 | $647,977,965 |
| 2023-06-30 | Vanguard Group Inc | 10% | 3,603,014 | $642,021,073 |
| 2023-06-30 | FMR, LLC | 7% | 2,434,974 | $433,888,023 |
| 2023-06-30 | Wellington Management Group, LLP | 4% | 1,352,723 | $241,041,714 |
| 2023-06-30 | Artisan Partners Limited Partnership | 3% | 1,147,784 | $204,523,633 |
| 2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 1,091,050 | $194,414,202 |
| 2023-06-30 | State Street Corporation | 3% | 1,018,186 | $181,430,565 |
| 2023-06-30 | JP Morgan Chase & Company | 2% | 835,138 | $148,813,242 |
| 2023-06-30 | Invesco Ltd. | 2% | 773,776 | $137,879,147 |
| 2023-09-30 | Allspring Global Investments Holdings, LLC | 2% | 645,634 | $115,045,524 |
